Gene expression profiles are differently affected by pimecrolimus and betamethasone in lesional skin in atopic dermatitis

被引：0
|
作者：
Scherer, Andreas [2 ,3 ]
Braeutigam, Matthias [2 ]
Schwarz, Thomas [1 ]
Foelster-Holst, Regina [1 ]
Proksch, Ehrhardt [1 ]
Jensen, Jens-Michael [1 ]
机构：
[1] Univ Kiel, Univ Hostpitals Schleswig Holstein, Dept Dermatol Venerol & Allergol, D-24098 Kiel, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Spheromics, Kontiolahti, Finland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
    Jensen, J. M.
    Scherer, A.
    Wanke, C.
    Braeutigam, M.
    Bongiovanni, S.
    Letzkus, M.
    Staedtler, F.
    Kehren, J.
    Zuehlsdorf, M.
    Schwarz, T.
    Weichenthal, M.
    Foelster-Holst, R.
    Proksch, E.
    ALLERGY, 2012, 67 (03) : 413 - 423
  • [2] The gene expression program of lesional skin in atopic dermatitis
    Holt, K
    Mallon, D
    Cocks, B
    Holt, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (06) : A8 - A8
  • [3] Pimecrolimus but not betamethasone preserves antimicrobial protein expression in atopic dermatitis
    Jensen, J. M.
    Koehler, B.
    Harder, J.
    Braeutigam, M.
    Schwarz, T.
    Foelster-Holst, R.
    Proksch, E.
    Glaeser, R.
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (03) : 268 - 268
  • [4] Differential impact of pimecrolimus compared to betamethasone treatment on gene expression profile in atopic dermatitis
    Scherer, A.
    Wanke, C.
    Jensen, J. M.
    Braeutigam, M.
    Foelster-Holst, R.
    Staedtler, F.
    Kehren, J.
    Zuehlsdorf, M.
    Proksch, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S47 - S47
  • [5] Pimecrolimus but not betamethasone treatment normalizes the structure of the skin barrier in atopic dermatitis
    Jensen, J.
    Pfeiffer, S.
    Witt, M.
    Foelster-Holst, R.
    Proksch, E.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 231 - 231
  • [6] Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis
    Jensen, Jens-Michael
    Pfeiffer, Stephan
    Witt, Magdalena
    Braeutigam, Matthias
    Neumann, Claudia
    Weichenthal, Michael
    Schwarz, Thomas
    Foelster-Holst, Regina
    Proksch, Ehrhardt
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (05) : 1124 - 1133
  • [7] Pimecrolimus but not betamethasone sustains elevated antimicrobial protein expression in atopic dermatitis
    Jensen, J.
    Glaeser, R.
    Koehler, B.
    Harder, J.
    Braeutigam, M.
    Schwarz, T.
    Proksch, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S182 - S182
  • [8] Expression of epidermal differentiation and antimicrobial proteins after treatment with pimecrolimus versus betamethasone in atopic dermatitis
    Jensen, J.
    Scherer, A.
    Braeutigam, M.
    Glaeser, R.
    Witt, M.
    Foelster-Holst, R.
    Proksch, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S16 - S16
  • [9] Improvement in the skin barrier and induction of epidermal differentiation after treatment with pimecrolimus versus betamethasone in atopic dermatitis
    Jensen, J. M.
    Pfeiffer, S.
    Witt, M.
    Neumann, C.
    Fölster-Holst, R.
    Proksch, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 19 - 19
  • [10] Caspase-14 expression is increased in lesional skin of atopic dermatitis
    Proksch, E.
    Neumann, C.
    Foelster-Holst, R.
    Jensen, J. M.
    Schwarz, T.
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (03) : 245 - 245
12345